• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchRain Oncology
    Picture of Rain Oncology logo

    RAIN — Rain Oncology News Story

    $1.210.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro Cap
    • Market Cap
      $44.03m
    • Enterprise Value
      -$33.29m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RAIN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RAIN Dividends
    All News

    NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

    Picture of Rain Oncology logoRain Oncology
    23/04/2021 08:58
    NASDAQ TRADE HALT CONTINUES  RAIN.O  REASON NOT AVAILABLE AT 03:58 AM
    

    Recent news on Rain Oncology

    See all news
    • Brief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing

      30/06/2026 22:30
    • Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing

      14/04/2026 21:26
    • Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI

      19/01/2024 13:09
    • Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights

      13/12/2023 23:26
    • Brief: Rain Oncology Q3 Net Income USD -7.034 Million

      09/11/2023 21:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.